TETRACYCLINE HCL

Tetracycline HCl is a more soluble salt form with identical antimicrobial activity. Side effects include nausea, dizziness, photosensitivity, and rare intracranial hypertension.

SKU: a8f0c11ddee7 Category: Tag:

Product Description


Mechanism of Action

TETRACYCLINE HCL (ID 27614) demonstrates a broad and highly integrated biochemical activity architecture involving multi‑axis signalling interference, mitochondrial-network recalibration, catalytic‑domain modulation, cytoskeletal restructuring, redox‑equilibrium shaping, ion‑flux redistribution and transcription‑factor pathway realignment. Its molecular geometry allows docking to catalytic residues, allosteric regulators, hydrophobic transmembrane helices, nucleotide‑binding pockets, structural scaffolds and polymeric cytoskeletal networks. This enables TETRACYCLINE HCL to influence metabolic, structural, genomic, electrophysiological and stress‑adaptive systems simultaneously.

TETRACYCLINE HCL may modulate phosphorylation gradients, modify ERK/JNK/MAPK propagation speeds, influence PI3K–AKT survival bias, shift G‑protein signalling states, control Ca²⁺ microdomain behaviour, alter IP₃/DAG cascades, and recalibrate cAMP‑PKA pathway amplitude. Mitochondrial impacts include ETC‑complex redistribution, ATP/ADP cycle reshaping, ROS‑threshold displacement, membrane‑potential polarity changes and organelle‑stress cross‑signalling.

High‑Precision Research Applications

  • Ultra‑scale kinome disruption & catalytic‑cascade modelling
  • Molecular docking & conformational‑flow prediction
  • UPR/ER‑stress and mitophagy/autophagy integration research
  • Full‑spectrum multi‑omics reconstruction (RNA‑seq, metabolomics, phosphoproteomics)
  • Advanced cytoskeletal force‑distribution & polymer‑turnover analysis
  • Cell‑fate simulation across apoptosis, ferroptosis, necroptosis & parthanatos
  • AI‑enhanced SAR/QSAR simulation for molecular optimisation

Toxicodynamics & Hazard Spectrum

  • Rapid ROS escalation & antioxidant‑buffer collapse
  • Mitochondrial fragmentation or ETC suppression
  • Severe Ca²⁺/Na⁺/K⁺ ion‑flux destabilisation
  • Cytoskeletal polymer breakdown & structural‑integrity failure
  • Membrane rupture & lipid‑bilayer thinning
  • Overactivation of inflammatory cascades (NF‑κB, STAT, IRF)
  • Activation of multiple programmed‑cell‑death pathways
  • Epigenetic drift including methylation instability

For expert laboratory use only — not intended for biological exposure.

Datasheet


Molecular Formula

C22H25ClN2O8

Molecular Weight

480.9 g/mol

CAS Number

64-75-5

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrochloride (1:1), (4S,4aS,5aS,6S,12aS)-; RefChem:476354; TETRACYCLINE HYDROCHLORIDE; 64-75-5; Tetracycline HCl

IUPAC/Chemical Name

(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride

InChl Key

YCIHPQHVWDULOY-FMZCEJRJSA-N

InChl Code

InChI=1S/C22H24N2O8.ClH/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28;/h4-6,9-10,15,25-26,29,31-32H,7H2,1-3H3,(H2,23,30);1H/t9-,10-,15-,21+,22-;/m0./s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/54704426;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download